These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20398587)

  • 41. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving communication about viral hepatitis in Africa.
    Shimakawa Y; Pourette D; Bainilago L; Enel C; Sombié R; Rado R; Lemoine M; Giles-Vernick T
    Lancet Infect Dis; 2017 Jul; 17(7):688-689. PubMed ID: 28653627
    [No Abstract]   [Full Text] [Related]  

  • 43. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
    Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
    Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.
    Tserenpuntsag B; Nelson K; Lamjav O; Triner W; Smith P; Kacica M; McNutt LA
    Transfusion; 2010 Jan; 50(1):92-9. PubMed ID: 19788639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [HBV and HCV coinfections in children--own investigations].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral hepatitis and HIV in Africa.
    Modi AA; Feld JJ
    AIDS Rev; 2007; 9(1):25-39. PubMed ID: 17474311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevalence of chronic viral hepatitis in drug abusers].
    Osztrogonácz H; Gerevich J; Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 2000 Apr; 141(14):715-8. PubMed ID: 10803013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits and adverse effects of hepatitis C screening: early results of a screening program.
    Trepka MJ; Zhang G; Leguen F; Obiaja K; Malow RM; De La Rosa M
    J Public Health Manag Pract; 2007; 13(3):263-9. PubMed ID: 17435493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Introduction to chronic hepatitis B infection.
    Wright TL
    Am J Gastroenterol; 2006; 101 Suppl 1():S1-6. PubMed ID: 16448446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral hepatitis in patients on hemodialysis.
    Winston A; Wurcel AG; Gordon C; Goyal N
    Semin Dial; 2020 May; 33(3):254-262. PubMed ID: 32394502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global hepatitis, migration and its impact on Western healthcare.
    Ahmed F; Foster GR
    Gut; 2010 Aug; 59(8):1009-11. PubMed ID: 20639244
    [No Abstract]   [Full Text] [Related]  

  • 53. Surgeon and hepatitis B and C.
    Akhtar J
    J Coll Physicians Surg Pak; 2004 Jun; 14(6):327-8. PubMed ID: 15233882
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatitis B and C viral infections in chronic liver disease: a population based study in Qatar.
    Rikabi A; Bener A; Al-Marri A; Al-Thani S
    East Mediterr Health J; 2009; 15(4):778-84. PubMed ID: 20187528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Institute of Medicine report on viral hepatitis: a call to action.
    Sanyal AJ;
    Hepatology; 2010 Mar; 51(3):727-8. PubMed ID: 20198626
    [No Abstract]   [Full Text] [Related]  

  • 57. Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer.
    Fusco M; Girardi E; Piselli P; Palombino R; Polesel J; Maione C; Scognamiglio P; Pisanti FA; Solmone M; Di Cicco P; Ippolito G; Franceschi S; Serraino D;
    Eur J Cancer; 2008 Apr; 44(6):847-53. PubMed ID: 18313290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatitis C and B (HCV, HBV)].
    Violante MD
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():101-3. PubMed ID: 17037789
    [No Abstract]   [Full Text] [Related]  

  • 59. [Suggested procedure in dealing with chronically infected staff members (infections with HBV, HCV, HIV) in medical institutions in Bremen].
    Wunderle W; Hittmann F; von Schwarzkopf H
    Gesundheitswesen; 2004 Feb; 66(2):121-5. PubMed ID: 14994211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV, hepatitis B and hepatitis C coinfection in Kenya.
    Harania RS; Karuru J; Nelson M; Stebbing J
    AIDS; 2008 Jun; 22(10):1221-2. PubMed ID: 18525268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.